- Home
- SEAT vs QSI Comparison
SEAT vs QSI Comparison
Compare SEAT & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEAT
- QSI
- Stock Information
- Founded
- SEAT 2001
- QSI 2013
- Country
- SEAT United States
- QSI United States
- Employees
- SEAT N/A
- QSI N/A
- Industry
- SEAT Industrial Machinery/Components
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- SEAT Industrials
- QSI Health Care
- Exchange
- SEAT Nasdaq
- QSI Nasdaq
- Market Cap
- SEAT 622.1M
- QSI 288.2M
- IPO Year
- SEAT N/A
- QSI N/A
- Fundamental
- Price
- SEAT $4.48
- QSI $1.92
- Analyst Decision
- SEAT Strong Buy
- QSI Buy
- Analyst Count
- SEAT 10
- QSI 2
- Target Price
- SEAT $6.73
- QSI $3.25
- AVG Volume (30 Days)
- SEAT 1.1M
- QSI 24.0M
- Earning Date
- SEAT 03-04-2025
- QSI 02-27-2025
- Dividend Yield
- SEAT N/A
- QSI N/A
- EPS Growth
- SEAT N/A
- QSI N/A
- EPS
- SEAT N/A
- QSI N/A
- Revenue
- SEAT $774,076,000.00
- QSI $2,266,000.00
- Revenue This Year
- SEAT $10.17
- QSI $193.90
- Revenue Next Year
- SEAT $4.02
- QSI $173.18
- P/E Ratio
- SEAT N/A
- QSI N/A
- Revenue Growth
- SEAT 13.91
- QSI 232.26
- 52 Week Low
- SEAT $3.24
- QSI $0.61
- 52 Week High
- SEAT $6.41
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- SEAT 49.56
- QSI 42.87
- Support Level
- SEAT $4.13
- QSI $2.26
- Resistance Level
- SEAT $4.78
- QSI $2.12
- Average True Range (ATR)
- SEAT 0.26
- QSI 0.25
- MACD
- SEAT -0.08
- QSI -0.11
- Stochastic Oscillator
- SEAT 26.67
- QSI 7.53
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.